资讯

The company has received final approval from the US Food & Drug Administration (USFDA) for Sacubitril and Valsartan Tablets in strengths of 24 mg/26 mg, 49 mg/51 mg, and 97 mg/103 mg, Alembic said ...
Entresto 800mg/200mL oral suspension can be prepared in a concentration of 4mg/mL (sacubitril/valsartan 1.96/2.04mg/mL). Use Entresto 49/51mg tablets in the preparation of the suspension.